Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP418575.RA6oyS4iCt2gVMgQAzuldOjjSaT0lnXSOd8VDfxvOOugs130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP418575.RA6oyS4iCt2gVMgQAzuldOjjSaT0lnXSOd8VDfxvOOugs130_assertion type Assertion NP418575.RA6oyS4iCt2gVMgQAzuldOjjSaT0lnXSOd8VDfxvOOugs130_head.
- NP418575.RA6oyS4iCt2gVMgQAzuldOjjSaT0lnXSOd8VDfxvOOugs130_assertion description "[We conclude that NY-ESO-1 is an immunogenic antigen in neuroblastoma patients and represents a candidate target for immune-based therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP418575.RA6oyS4iCt2gVMgQAzuldOjjSaT0lnXSOd8VDfxvOOugs130_provenance.
- NP418575.RA6oyS4iCt2gVMgQAzuldOjjSaT0lnXSOd8VDfxvOOugs130_assertion evidence source_evidence_literature NP418575.RA6oyS4iCt2gVMgQAzuldOjjSaT0lnXSOd8VDfxvOOugs130_provenance.
- NP418575.RA6oyS4iCt2gVMgQAzuldOjjSaT0lnXSOd8VDfxvOOugs130_assertion SIO_000772 14583496 NP418575.RA6oyS4iCt2gVMgQAzuldOjjSaT0lnXSOd8VDfxvOOugs130_provenance.
- NP418575.RA6oyS4iCt2gVMgQAzuldOjjSaT0lnXSOd8VDfxvOOugs130_assertion wasDerivedFrom befree-2016 NP418575.RA6oyS4iCt2gVMgQAzuldOjjSaT0lnXSOd8VDfxvOOugs130_provenance.
- NP418575.RA6oyS4iCt2gVMgQAzuldOjjSaT0lnXSOd8VDfxvOOugs130_assertion wasGeneratedBy ECO_0000203 NP418575.RA6oyS4iCt2gVMgQAzuldOjjSaT0lnXSOd8VDfxvOOugs130_provenance.